News

Adaptive deep brain stimulation provides remarkable relief for 70-year-old conductor Rand Laycock, whose Parkinson's tremors impacted his musical career until a breakthrough in treatment.
A team at Stanford University School of Medicine in Palo Alto, Calif., was set to connect two Parkinson's patients to a new type of deep brain stimulation device, or "brain pacemaker," developed ...
A man who has been battling Parkinson’s disease for seven years shared a video on TikTok demonstrating the astounding results that deep brain stimulation has had on his ability to use his hands. ...
Deep brain stimulation (DBS) is already being used to treat physical symptoms—such as tremors—in people living with Parkinson's. But, until now, its potential to help relieve non-movement ...
Parkinson's disease disrupts the chemistry of the brain, progressively hampering a person's movements. Deep brain stimulation, which uses electric pulses, can often get patients moving again.
Deep brain stimulation (DBS) is often used in refractory cases of Parkinson’s disease as well as in a number of other movement disorders. Electrodes are placed in deep nuclei of the brain, and ...
Adaptive deep brain stimulation has virtually eliminated the most debilitating motor symptoms for some Parkinson’s patients and considerably improved their lives. At 40, Keith Krehbiel was a ...
Deep brain stimulation, the procedure she underwent, was approved by the U.S. Food and Drug Administration in 1997 to treat Parkinson’s tremor, according to the Parkinson's Foundation.
An intelligent brain pacemaker Shawn Connolly, an artist and non-profit founder for skateboarders and community youth, follows the doctor’s directions while testing deep brain stimulation for ...
Deep brain stimulation (DBS) is a neurosurgical surgery that uses implanted electrodes and electrical stimulation to treat movement disorders in a Parkinson's disease patient. TheHealthSite.com ...
*Köhler RM et al. Dopamine and deep brain stimulation accelerate the neural dynamics of volitional action in Parkinson's disease. Brain 2024 Oct 3. doi: 10.1093/brain/awae219. About the study ...